Effects of topical glucocorticoids on in vitro lactoferrin glandular secretion: Comparison between human upper and lower airways

Journal of Allergy and Clinical Immunology

Volumn 106, Issue 6, 2000, Pages 1053-1062

  Roca Ferrer, Jordi ^a   Mullol, Joaquim ^a,b   Pérez, María ^a   Xaubet, Antoni ^a,c   Molins, Laureano ^d   De Haro, Josep ^e   Shelhamer, James ^f   Picado, César ^a,c  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

^c Institut Clínic de Pneumologia i Cirurgia Toràcica   (Spain)

^d HOSPITAL UNIVERSITARI SAGRAT COR   (Spain)

^e Hospital Municipal de Badalona   (Spain)

^f NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Beclomethasone dipropionate; Bronchial mucosa; Budesonide; Glandular secretion; Glucocorticoids; Lactoferrin; Lipocortin 1; Methacholine; Mucus hypersecretion; Nasal mucosa

Indexed keywords

BECLOMETASONE DIPROPIONATE; BUDESONIDE; LACTOFERRIN;

ADULT; ALLERGY; ARTICLE; ATOPY; BRONCHUS SECRETION; CORTICOSTEROID THERAPY; DRUG EFFECT; FEMALE; HUMAN; HUMAN TISSUE; MALE; MUCUS SECRETION; NOSE SECRETION; PRIORITY JOURNAL;

EID: 0034538063     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2000.110476     Document Type: Article

References (46)

1. Lactoferrin: Molecular structure and biological function
2. Distinct granule populations in human neutrophils and lysosomal organelles identified by immuno-electron microscopy
3. The serous cell
4. Mucus secretion and inflammation
5. Comparison of human nasal mucosal secretion in vivo and in vitro
6. Spontaneous release of submucosal gland serous and mucous cell macromolecules from human nasal explants in vitro
7. Pathophysiology of rhinitis. Lactoferrin and lysozyme in nasal secretions
8. 3 muscarinic antagonists inhibit human nasal glandular secretion in vitro
9. Muscarinic receptors and the cholinergic pathway of the respiratory tract
10. Basic of muscarinic physiology
11. Anti-inflammatory actions of glucocorticoids: Molecular mechanisms
12. A comparison of the efficacy and patient acceptability of budesonide and beclomethasone dipropionate aqueous nasal sprays in patients with perennial rhinitis
13. A parallel-group comparison of budesonide and beclomethasone dipropionate for the treatment of perennial allergic rhinitis in adults
14. Corticosteroids in the treatment of asthma
15. Dexamethasone inhibits respiratory glycoconjugate secretion from feline airways in vitro by the induction of lipocortin (lipomodulin) synthesis
16. Direct inhibitory action of glucocorticoid on glycoconjugate secretion from airway submucosal glands
17. The effects of corticosteroids on mucous glycoprotein secretion from human airways in vitro
18. Topical corticosteroids potentiate mucin secretion in the normal nose
19. Lipocortin-1: Cellular mechanisms and clinical relevance
20. Lipocortin 1 production by human alveolar macrophages
21. Macrophage-specific eicosanoid synthesis inhibition and lipocortin-1 induction by glucocorticoids
22. Lipocortin-1 distribution in bronchoalveolar lavage from healthy human lung: Effect of prednisolone
23. Lung type II cell and macrophage annexin-I release: Differential effects of two glucocorticoids
24. Eicosanoids and lipocortin-1 in BAL fluid in asthma: Effects of smoking and inhaled glucocorticoids
25. Dextran polymer conjugate two-step visualization system for immunohistochemistry. A comparison of EnVision+ with two three-step avidin-biotin techniques
26. Human tracheobronchial submucosal gland cells in culture
27. Histological features of the airways in asthma and COPD
28. Anticholinergic properties of brompheniramine, chlorphaniramine, and atropine in human nasal mucosa in vitro
29. Duration of action of intranasal atropine on methacholine-induced nasal secretions
30. Epithelial cells: Regulation of mucus secretion
31. Reduction of methacholine-induced nasal secretion by treatment with a new topical steroid in perennial non-allergic rhinitis
32. Eosinophils, secretory responsiveness and glucocorticoid-induced effects on the nasal mucosa during a weak pollen season
33. Effects of topical anti-inflammatory drugs on eosinophil survival primed by epithelial cells. Additive effects of glucocorticoids and nedocromil sodium
34. Effect of topical anti-inflammatory drugs on epithelial cell-induced eosinophil survival and GM-CSF secretion
35. High-dose inhaled steroid therapy for asthma
36. A comparison of inhaled budesonide and beclomethasone dipropionate in childhood asthma
37. A comparison of budesonide and beclomethasone dipropionate sprays in the treatment of seasonal allergic rhinitis
38. A comparison of budesonide and beclomethasone dipropionate nasal aerosols in ragweed-induced rhinitis
39. Activation of beclomethasone dipropionate by hydrolysis to beclomethasone-17-monopropionate
40. Mechanisms of action of glucocorticoids. Applicability to the treatment of respiratory inflammation
41. Effect of steroids hormones on muscarinic receptors of bronchial smooth muscle
42. Glucocorticoid treatment decreases muscarinic receptor expression in canine airway smooth muscle
43. Glucocorticoid modulation of muscarinic and beta-adrenegic receptors in guinea pig lung
44. 2 by lipocortins is an indirect effect of substracte/lipocortin interaction
45. Effects of arachidonic acid, monohydroxy-eicosatetraenoic acid and prostaglandins on the release of mucous glycoproteins from human airways in vitro
46. 4 increase the release of mucus from human airways in vitro